Not Using Anthracycline-based Therapies  Patients accumulate loss of heterozygosity & MSI

Not Using Anthracycline-based Therapies Patients accumulate loss of heterozygosity & MSI

User Photo
moasc

2 years
88 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
ara A Hurvitz, MD, FACP Associate Professor of Medicine Director, Breast Oncology, explains Not Using Anthracycline-based Therapies Patients accumulate loss of heterozygosity & MSI at the 2018 Oncology Summit in Huntington Beach, CA

Go to: http://www.moasc.org for more information
Up Next Autoplay
>